The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Risk-Reducing Salpingo-oophorectomy in Women with a BRCA1 or BRCA2 Mutation
Open accessAbstract
BACKGROUND: Risk-reducing salpingo-oophorectomy is often considered by carriers of BRCA mutations who have completed childbearing. However, there are limited data supporting the efficacy of this approach. We prospectively compared the effect of risk-reducing salpingo-oophorectomy with that of surveillance for ovarian cancer on the incidence of subsequent breast cancer and BRCA-related gynecologic cancers in women with BRCA mutations. METHODS: All women with BRCA1 or BRCA2 mutations identified during a six-year period were offered enrollment in a prospective follow-up study. A total of 170 women 35 years of age or older who had not undergone bilateral oophorectomy chose to undergo either surveillance for ovarian cancer or risk-reducing salpingo-oophorectomy. Follow-up involved an annual questionnaire, telephone contact, and reviews of medical records. The time to cancer in the two groups was compared by Kaplan-Meier analysis and a Cox proportional-hazards model. RESULTS: During a mean follow-up of 24.2 months, breast cancer was diagnosed in 3 of the 98 women who chose risk-reducing salpingo-oophorectomy and peritoneal cancer was diagnosed in 1 woman in this group. Among the 72 women who chose surveillance, breast cancer was diagnosed in 8, ovarian cancer in 4, and peritoneal cancer in 1. The time to breast cancer or BRCA-related gynecologic cancer was longer in the salpingo-oophorectomy group, with a hazard ratio for subsequent breast cancer or BRCA-related gynecologic cancer of 0.25 (95 percent confidence interval, 0.08 to 0.74). CONCLUSIONS: Salpingo-oophorectomy in carriers of BRCA mutations can decrease the risk of breast cancer and BRCA-related gynecologic cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
Modeling Survival Data: Extending the Cox Model
Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D. T., Weber, B., Lenoir, G., Chang-Claude, J., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301749 · Cited by 3,037
The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews
Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C., & Tucker, M. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362001 · Cited by 2,281
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
Easton, D. F., Ford, D., & Bishop, D. T. (1995) · PubMed Central · Cited by 1,602
Cancer Risks in BRCA2 Mutation Carriers
Breast Cancer Linkage Consortium, T. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.15.1310 · Cited by 1,527
Menopause and the Risk of Coronary Heart Disease in Women
Colditz, G. A., Willett, W. C., Stampfer, M. J., Rosner, B., Speizer, F. E., & Hennekens, C. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704303161801 · Cited by 1,148
Breast Cancer after Prophylactic Bilateral Mastectomy in Women with a BRCA1 or BRCA2 Mutation
Meijers-Heijboer, H., van Geel, B., van Putten, W. L. J., Henzen-Logmans, S. C., Seynaeve, C., Menke-Pluymers, M. B. E., Bartels, C. C. M., Verhoog, L. C., van den Ouweland, A. M. W., Niermeijer, M. F., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107193450301 · Cited by 973
Burke, W. (1997) · JAMA · doi:10.1001/jama.277.12.997 · Cited by 955
Breast Cancer Risk After Bilateral Prophylactic Oophorectomy in BRCA1 Mutation Carriers
Rebbeck, T. R., Levin, A. M., Eisen, A., Snyder, C., Watson, P., Cannon-Albright, L., Isaacs, C., Olopade, O., Garber, J. E., Godwin, A. K., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.17.1475 · Cited by 672
Oral Contraceptives and the Risk of Hereditary Ovarian Cancer
Narod, S. A., Risch, H., Moslehi, R., Dørum, A., Neuhausen, S., Olsson, H., Provencher, D., Radice, P., Evans, G., Bishop, S., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808133390702 · Cited by 615
Unusual case of Smith‐Lemli‐Opitz syndrome “type II”
Seller, M. J., Russell, J., & Tint, G. S. (1995) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320560305 · Cited by 585
Screening for ovarian cancer: a pilot randomised controlled trial
Jacobs, I. J., Skates, S. J., MacDonald, N., Menon, U., Rosenthal, A. N., Davies, A. P., Woolas, R., Jeyarajah, A. R., Sibley, K., Lowe, D. G., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10261-1 · Cited by 560
Complications Leading to Surgery after Breast Implantation
Gabriel, S. E., Woods, J. E., O'Fallon, W. M., Beard, C. M., Kurland, L. T., & Melton, L. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703063361001 · Cited by 444
Outcome of Preventive Surgery and Screening for Breast and Ovarian Cancer in BRCA Mutation Carriers
Scheuer, L. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1260 · Cited by 404
Self-citationINTRA-ABDOMINAL CARCINOMATOSIS AFTER PROPHYLACTIC OOPHORECTOMY IN OVARIAN-CANCER-PRONE FAMILIES
Tobacman, J., Tucker, M., Kase, R., Greene, M., Costa, J., & Fraumeni, J. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92681-2 · Cited by 351
The Efficacy of Transvaginal Sonographic Screening in Asymptomatic Women at Risk for Ovarian Cancer
van Nagell, J. R., DePriest, P. D., Reedy, M. B., Gallion, H. H., Ueland, F. R., Pavlik, E. J., & Kryscio, R. J. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5816 · Cited by 345
Piver, M. S., Jishi, M. F., Tsukada, Y., & Nava, G. (1993) · Cancer · doi:10.1002/1097-0142(19930501)71:9<2751::aid-cncr2820710911>3.0.co;2-j · Cited by 321
BRCA-associated breast cancer in young women.
Robson, M., Gilewski, T., Haas, B., Levin, D., Borgen, P., Rajan, P., Hirschaut, Y., Pressman, P., Rosen, P. P., Lesser, M. L., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.5.1642 · Cited by 302
Self-citationSplit-Hand/Split-Foot Malformation Is Caused by Mutations in the p63 Gene on 3q27
Ianakiev, P., Kilpatrick, M. W., Toudjarska, I., Basel, D., Beighton, P., & Tsipouras, P. (2000) · The American Journal of Human Genetics · doi:10.1086/302972 · Cited by 292
Menstrual Factors and Risk of Breast Cancer
Brinton, L. A., Schairer, C., Hoover, R. N., & Fraumeni, J. F. (1988) · Cancer Investigation · doi:10.3109/07357908809080645 · Cited by 249
A Genetic Epidemiological Study of Carcinoma of the Fallopian Tube
Aziz, S., Kuperstein, G., Rosen, B., Cole, D., Nedelcu, R., McLaughlin, J., & Narod, S. A. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2000.6095 · Cited by 222
The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan, J. M., Offit, K., Foulkes, W. D., Robson, M. E., Wacholder, S., Eng, C. M., Karp, S. E., & Begg, C. B. (2001) · PubMed · Cited by 218
Self-citationPaley, P. J., Swisher, E. M., Garcia, R. L., Agoff, S. N., Greer, B. E., Peters, K. L., & Goff, B. A. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2000.6071 · Cited by 189
Prophylactic oophorectomy in inherited breast/ovarian cancer families.
Struewing, J. P., Watson, P., Easton, D., Ponder, B. A. J., Lynch, H. T., & Tucker, M. A. (1995) · PubMed · Cited by 184
Risk of Endometrial Carcinoma Associated with BRCA Mutation
Levine, D. A., Lin, O., Barakat, R. R., Robson, M. E., McDermott, D. A., Cohen, L., Satagopan, J. M., Offit, K., & Boyd, J. A. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2000.6082 · Cited by 144
Self-citationOsteoporosis after Oophorectomy for Non-malignant Disease in Premenopausal Women
Aitken, J. M., Hart, D. M., Anderson, J., Lindsay, R., Smith, D. A., & Speirs, C. F. (1973) · BMJ · doi:10.1136/bmj.2.5862.325 · Cited by 142
Prophylactic Surgery in Women With a Hereditary Predisposition to Breast and Ovarian Cancer
Eisen, A. F., Rebbeck, T. R., Wood, W. C., & Weber, B. L. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.9.1980 · Cited by 140
Schorge, J. O., Muto, M. G., Welch, W. R., Bandera, C. A., Rubin, S. C., Bell, D. A., Berkowitz, R. S., & Mok, S. C. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.11.841 · Cited by 129
Breast cancer risk associated with gynecologic surgery and indications for such surgery
Schairer, C., Persson, I. R., Falkeborn, M., Naessén, T., Troisi, R. J., & Brinton, L. A. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970117)70:2<150::aid-ijc2>3.0.co;2-w · Cited by 125
Ultrasound screening for familial ovarian cancer
Bourne, T., Whitehead, M. I., Campbell, S. C., Royston, P. J., Bhan, V., & Collins, W. P. (1991) · Gynecologic Oncology · doi:10.1016/0090-8258(91)90051-6 · Cited by 121
Cancer Incidence in a Population of Jewish Women at Risk of Ovarian Cancer
Liede, A., Karlan, B. Y., Baldwin, R. L., Platt, L. D., Kuperstein, G., & Narod, S. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1570 · Cited by 97
Hysterectomy, Oophorectomy in Premenopause, and Risk of Breast Cancer
Parazzini, F., Braga, C., Vecchia, C. L., Negri, E., Acerboni, S., & Franceschi, S. (1997) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(97)00295-0 · Cited by 83
Fry, A. M., Busby‐Earle, C., Rush, R., & Cull, A. (2001) · Psycho-Oncology · doi:10.1002/pon.512 · Cited by 76
Hysterectomy, oophorectomy, and heart disease risk factors in older women.
Kritz‐Silverstein, D. C., Barrett-Connor, E. L., & WINGARD, D. L. (1997) · American Journal of Public Health · doi:10.2105/ajph.87.4.676 · Cited by 61
Cited by
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
King, M.-C., Marks, J. H., & Mandell, J. B. (2003) · Science · doi:10.1126/science.1088759 · Cited by 2,229
Cannistra, S. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041842 · Cited by 2,129
Jayson, G. C., Kohn, E. C., Kitchener, H. C., & Ledermann, J. A. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62146-7 · Cited by 1,850
Kriege, M., Brekelmans, C. T. M., Boetes, C., Besnard, P. E., Zonderland, H. M., Obdeijn, I. M., Manoliu, R. A., Kok, T., Peterse, H., Tilanus-Linthorst, M. M. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031759 · Cited by 1,687
Domchek, S. M. (2010) · JAMA · doi:10.1001/jama.2010.1237 · Cited by 1,494
Metadata
- Authors
- Kauff, N. D., Satagopan, J. M., Robson, M. E., Scheuer, L., Hensley, M., Hudis, C. A., Ellis, N. A., Boyd, J., Borgen, P. I., Barakat, R. R., Norton, L., Castiel, M., Nafa, K., & Offit, K.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-05-23
- Volume
- 346
- Issue
- 21
- Pages
- 1609-1615
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2045733577
- Cited by
- 1,251
- References
- 37
- FWCI
- 44.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.